253 related articles for article (PubMed ID: 9611279)
1. [Use of 99mTc-tetrofosmin scintigraphy in the diagnosis of patients with hyperparathyroidism].
Vallejos V; Martín-Comín J; Mora J; González MT; Rafecas A; Muñoz A; Fernández A; Castell M; Ricard Y; Ramos M
Rev Esp Med Nucl; 1998; 17(2):94-101. PubMed ID: 9611279
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
Vallejos V; Martin-Comin J; Gonzalez MT; Rafecas R; Muñoz A; Fernãndez A; Mora J; Ramos M
Clin Nucl Med; 1999 Dec; 24(12):959-64. PubMed ID: 10595477
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
[TBL] [Abstract][Full Text] [Related]
4. Localization of parathyroid glands using technetium-99m-tetrofosmin imaging.
Ishibashi M; Nishida H; Strauss HW; Kojima K; Fujito H; Watanabe J; Hiromatsu Y; Hayabuchi N
J Nucl Med; 1997 May; 38(5):706-11. PubMed ID: 9170432
[TBL] [Abstract][Full Text] [Related]
5. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.
Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P
Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734
[TBL] [Abstract][Full Text] [Related]
6. Quantitative comparison of technetium-99m tetrofosmin and thallium-201 images of the thyroid and abnormal parathyroid glands.
Giordano A; Marozzi P; Meduri G; Ficola U; Calcagni ML; Vaccaro A; Rubini G; Attard M; Li Puma M; Ricci R; Corsello S
Eur J Nucl Med; 1999 Aug; 26(8):907-11. PubMed ID: 10436206
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
8. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m tetrofosmin parathyroid imaging in patients with primary hyperparathyroidism.
Hiromatsu Y; Ishibashi M; Nishida H; Okuda S; Miyake I
Intern Med; 2000 Feb; 39(2):101-6. PubMed ID: 10732824
[TBL] [Abstract][Full Text] [Related]
10. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
[TBL] [Abstract][Full Text] [Related]
11. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
Fröberg AC; Valkema R; Bonjer HJ; Krenning EP
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
[TBL] [Abstract][Full Text] [Related]
12. [Scintigraphic images im primary hyperparathyroidism with 99m Tc-Tetrofosmin].
Mazzini JU; de Freitas E; Ulyssea R
Rev Esp Med Nucl; 1998; 17(2):89-93. PubMed ID: 9611278
[TBL] [Abstract][Full Text] [Related]
13. Validity of dual tracer 99mTc-tetrofosmin and 99mTc-pertechnetate subtraction parathyroid scintigraphy in patients with primary and secondary hyperparathyroidism.
Dugonjić S; Ajdinović B; Cerović S; Janković Z
Vojnosanit Pregl; 2009 Dec; 66(12):949-53. PubMed ID: 20095513
[TBL] [Abstract][Full Text] [Related]
14. The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism.
Spanu A; Falchi A; Manca A; Marongiu P; Cossu A; Pisu N; Chessa F; Nuvoli S; Madeddu G
J Nucl Med; 2004 Jan; 45(1):40-8. PubMed ID: 14734671
[TBL] [Abstract][Full Text] [Related]
15. [Disagreement between findings of 99mTc-MIBI and 99mTc-pertechnetate scintigraphy scans in patients with primary hyperparathyroidism].
Dolezal J; Horácek J; Ceeová V; Vizd'a J
Vnitr Lek; 2004 Jan; 50(1):72-5. PubMed ID: 15015233
[TBL] [Abstract][Full Text] [Related]
16. Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination Tc-99m-pertechnetate and Tc-99m-sestamibi radionuclide scans.
Wei JP; Burke GJ; Mansberger AR
Ann Surg; 1994 May; 219(5):568-72; discussion 572-3. PubMed ID: 8185405
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m-sestamibi/thallium-201 mismatch of thyroid and parathyroid adenoma in chronic renal failure.
Pijpers R; van Loon BJ; Roos JC; Hoekstra OS
J Nucl Med; 1995 May; 36(5):826-8. PubMed ID: 7738659
[TBL] [Abstract][Full Text] [Related]
18. Thallium-technetium-subtraction scintigraphy in secondary hyperparathyroidism.
Adalet I; Hawkins T; Clark F; Wilkinson R
Eur J Nucl Med; 1994 Jun; 21(6):509-13. PubMed ID: 8082665
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid imaging with 99Tcm-tetrofosmin.
Giordano A; Meduri G; Marozzi P
Nucl Med Commun; 1996 Aug; 17(8):706-10. PubMed ID: 8878132
[TBL] [Abstract][Full Text] [Related]
20. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
